DelMar Pharmaceuticals, Inc. Bonus & Incentive Agreements
7 Contracts & Agreements
- Amendment to the 2017 Omnibus Equity Incentive Plan of Kintara Therapeutics, Inc (Filed With SEC on September 27, 2022)
- Amendment to the 2017 Omnibus Equity Incentive Plan of Kintara Therapeutics, Inc (Filed With SEC on September 28, 2021)
- Amendment to the 2017 Omnibus Equity Incentive Plan of Kintara Therapeutics, Inc (Filed With SEC on September 18, 2020)
- Amendment No. 1 to Employment Agreement, Incentive Stock Option Grant Agreement and Nonqualified Stock Option Grant Agreement, dated as of February 8, 2017, by and between Adgero... (Filed With SEC on June 16, 2020)
- Amendment to the 2017 Omnibus Equity Incentive Plan of DelMar Pharmaceuticals, Inc (Filed With SEC on September 9, 2019)
- Form of DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan Option Grant Agreement (Filed With SEC on May 15, 2018)
- DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan (As Amended and Restated Effective as of February 1, 2018) (Filed With SEC on February 14, 2018)
